Placebo injections

DRUG4 trials

Sponsors

Centocor, Inc., University of California, Irvine, University of Campinas, Brazil, University of Southern California

Conditions

AlcoholAlcohol Use DisorderHereditary Spastic ParaplegiaObesity and OverweightPsoriasisRheumatoid Arthritis

Phase 1

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

CompletedNCT00585650

University of California, IrvinePsoriasis

Start: 2007-05-31End: 2008-05-31Updated: 2023-08-18

Phase 2

Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia

CompletedNCT02604186

University of Campinas, BrazilHereditary Spastic Paraplegia

Start: 2016-03-09End: 2017-03-15Updated: 2017-11-07

Tirzepatide for Alcohol Use Disorder

RecruitingNCT06994338

University of Southern CaliforniaAlcohol, Alcohol Use Disorder, Obesity and Overweight

Start: 2025-10-06End: 2026-08-31Target: 42Updated: 2025-10-14

Phase 3

A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

CompletedNCT00264537

Centocor, Inc.Rheumatoid Arthritis

Start: 2005-12-31End: 2012-06-30Updated: 2014-09-05

Related Papers

Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

The Journal of Rheumatology2016-11-0139 citations

Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis.

2016-07-1836 citations